Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

Petra Kaufmann, John L.P. Thompson, Gilberto Levy, Richard Buchsbaum, Jeremy Shefner, Lisa S. Krivickas, Jonathan Katz, Yvonne Rollins, Richard J. Barohn, Carlayne E. Jackson, Ezgi Tiryaki, Catherine Lomen-Hoerth, Carmel Armon, Rup Tandan, Stacy A. Rudnicki, Kourosh Rezania, Robert Sufit, Alan Pestronk, Steven P. Novella, Terry Heiman-PattersonEdward J. Kasarskis, Erik P. Pioro, Jacqueline Montes, Rachel Arbing, Darleen Vecchio, Alexandra Barsdorf, Hiroshi Mitsumoto, Bruce Levin

Research output: Contribution to journalArticlepeer-review

151 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III'. Together they form a unique fingerprint.

Medicine & Life Sciences